原人参二醇
茉莉酸甲酯
人参皂甙
人参
化学
生物反应器
产量(工程)
水解
酵母
酵母抽提物
生物化学
生物技术
生物
发酵
有机化学
医学
病理
基因
冶金
材料科学
替代医学
作者
Linggai Cao,Hao Chen,He Zhang,Quan Zhao,Xue Yin,Dongran Zheng,Chuanwang Li,Min‐Jun Kim,Pyol Kim,Zheyong Xue,Yu Wang,Yuhua Li
摘要
Abstract The rare ginsenosides are recognized as the functionalized molecules after the oral administration of Panax ginseng and its products. The sources of rare ginsenosides are extremely limited because of low ginsenoside contents in wild plants, hindering their application in functional foods and drugs. We developed an effective combinatorial biotechnology approach including tissue culture, immobilization, and hydrolyzation methods. Rh2 and nine other rare ginsenosides were produced by methyl jasmonate‐induced culture of adventitious roots in a 10 L bioreactor associated with enzymatic hydrolysis using six β‐glycosidases and their combination with yields ranging from 5.54 to 32.66 mg L −1 . The yield of Rh2 was furthermore increased by 7% by using immobilized BglPm and Bgp1 in optimized pH and temperature conditions, with the highest yield reaching 51.17 mg L −1 (17.06% of protopanaxadiol‐type ginsenosides mixture). Our combinatorial biotechnology method provides a highly efficient approach to acquiring diverse rare ginsenosides, replacing direct extraction from Panax plants, and can also be used to supplement yeast cell factories.
科研通智能强力驱动
Strongly Powered by AbleSci AI